Archiving Chain of Custody Records in Clinical Trials: Regulatory Strategies and Best Practices

Introduction: Why Archiving CoC Records Matters

Chain of Custody (CoC) records ensure accountability in the handling, transfer, and receipt of clinical samples throughout the trial lifecycle. These records serve as crucial evidence of sample integrity and regulatory compliance. Improper or incomplete archiving of these documents can jeopardize trial outcomes, lead to inspection findings, or even data rejection.

With FDA, EMA, and ICH-GCP increasingly focused on data integrity and traceability, the need for robust CoC record archiving systems has never been greater. This article provides a comprehensive guide on archiving CoC documentation — from regulatory expectations and retention timelines to real-world examples, digitization strategies, and CAPA considerations.

Regulatory Expectations for Chain of Custody Document Archiving

CoC logs, whether in paper or electronic format, must be archived in compliance with the following regulatory standards:

• FDA 21 CFR 312.57(c): Sponsors must retain records, including custody logs, for at least 2 years after the last approval or discontinuation.
• EMA GCP Directive 2005/28/EC: Requires retention of essential trial documents (including sample transfer logs) for at least 5 years post-trial or longer depending on national law.
• ICH GCP E6(R2): Emphasizes that documentation must be stored in a manner that ensures accessibility, legibility, and audit-readiness.

CoC records are part of the essential documents listed in ICH GCP and must be included in the Trial Master File (TMF) or equivalent systems. Their preservation is central to demonstrating compliance during audits and inspections.

Types of Chain of Custody Records That Require Archiving

• Site-generated custody logs (paper or electronic)
• Courier handover documentation
• Lab intake records (e-signature or stamped)
• Temperature tracking during shipment
• Deviation or discrepancy reports related to sample transfer
• Corrective and Preventive Action (CAPA) records associated with custody issues
• Training records for CoC SOPs

Paper vs. Electronic: Choosing the Right Archiving Format

The choice between paper and electronic storage depends on the sponsor’s archiving infrastructure, system validation, and regulatory acceptance in operational regions. Here’s a comparison:

Case Study: CAPA Triggered by Inaccessible Archived CoC Logs

During a sponsor inspection in Germany, EMA inspectors requested access to archived custody records for a study completed 6 years earlier. The CRO responsible for archiving had moved the boxes offsite and mislabeled the storage location. It took over 3 weeks to retrieve the records.

Findings: Lack of inventory tracking system and archiving SOP deficiencies.

CAPA Measures:

• Established a centralized document inventory system with barcode tracking
• Updated archiving SOP to include detailed indexing and access protocol
• Trained CRO staff on archiving procedures and sponsor access requirements

Best Practices for CoC Archiving

• Create an SOP for archiving chain of custody records specific to GCP requirements
• Maintain an up-to-date archive inventory log including box number, content, and retrieval pathway
• Ensure backup of electronic custody logs in multiple data centers (if cloud-based)
• Include CoC records in TMF/eTMF system with clear labeling
• Audit archive vendors annually and document qualification/agreements
• Ensure that scanned copies of paper custody logs are certified as true copies
• Track chain of custody record lifecycle from creation to destruction/retirement

Retention Timelines by Region

External Reference for Archiving Guidance

For broader expectations on retention and digital preservation of clinical records, refer to Japan’s RCT Portal which includes PMDA-linked documentation requirements.

Conclusion

Archiving chain of custody records is not just a storage task—it is a regulatory obligation. Whether through eTMF systems, physical archives, or hybrid models, clinical teams must implement traceable, audit-ready, and SOP-driven practices. By aligning with global retention timelines and inspection readiness strategies, sponsors can ensure the long-term integrity and usability of their sample custody records, even years after trial closure.

GCP Guide to Archiving Physical vs Electronic Clinical Records

Clinical records generated during trials are essential for regulatory review, scientific validation, and legal protection. Proper archiving—whether physical or electronic—is not just a best practice but a regulatory requirement. With the shift towards digitization, sponsors and CROs must understand the differences, compliance expectations, and best practices when choosing between physical and electronic archiving methods.

This guide outlines GCP requirements for clinical record archiving and compares the advantages and limitations of both formats, helping organizations make informed decisions aligned with global regulations.

What Records Must Be Archived in Clinical Trials?

According to ICH GCP E6(R2), clinical trials generate “essential documents” that demonstrate compliance and trial integrity. These documents must be archived to allow reconstruction of the trial, and include:

• Trial Master File (TMF)
• Case Report Forms (CRFs)
• Informed Consent Forms (ICFs)
• Source documents (lab reports, imaging)
• Monitoring visit reports
• Investigator brochures and protocols
• Audit trails and electronic logs

These documents must be retained for specified durations post-trial and stored in formats that preserve integrity and retrievability.

Retention Periods: A Quick Overview

Retention timelines vary by region and regulatory body. For example:

• EMA (EU): 25 years (per Regulation EU No. 536/2014)
• FDA (US): 2 years after approval or discontinuation (21 CFR 312.57)
• CDSCO (India): 5 years post-study
• ICH GCP: At least 2 years after final approval and discontinuation

Retention strategies must be aligned with the region of intended product registration and should be defined in the sponsor’s Pharma SOP documentation.

Archiving Physical Records: Legacy Yet Valuable

Advantages:

• Direct inspector familiarity with paper TMFs
• No dependency on digital systems or obsolescence
• Suitable for low-volume trials or single-site studies

Challenges:

• Expensive long-term storage and physical security needs
• Risks of environmental damage (moisture, fire, pests)
• Slower retrieval time, particularly during audits
• Inconsistent documentation control in case of human error

Physical storage facilities must be environmentally controlled, access restricted, and compliant with GMP audit checklist standards.

Archiving Electronic Records: Modern and Scalable

Advantages:

• Efficient indexing and retrieval
• Full audit trail availability
• Cloud-based backups and disaster recovery
• Supports global collaboration and inspections

Challenges:

• Requires 21 CFR Part 11 and EU Annex 11 compliance
• Cybersecurity risks if not encrypted and validated
• Long-term format compatibility concerns
• Higher initial validation and implementation costs

Validated archiving systems must meet CSV validation protocol standards, ensure data integrity, and restrict unauthorized access. Systems must also support metadata preservation and immutable records.

Hybrid Approach: Combining Strengths

Most sponsors adopt a hybrid model that leverages both physical and electronic formats:

• Store ICFs and source documents physically at the site
• Maintain eTMFs and EDC system records electronically
• Digitize paper records for redundancy and audit support
• Use electronic dashboards to track storage compliance

This approach ensures regulatory flexibility and operational resilience. It also supports faster preparation for inspections by agencies like CDSCO.

Key Compliance Requirements Across Formats

For Physical Archives:

• Secure, fire-resistant storage
• Document access logs
• Environmental monitoring and pest control
• Retention logs with destruction timelines

For Electronic Archives:

• Audit trails for each user access
• Role-based permissions
• Periodic integrity checks and re-validation
• Cloud backup and disaster recovery planning

Digital archiving systems also benefit activities like shelf life prediction and real-time data reconciliation.

Case Example: Transition to eTMF in Oncology Trials

A global oncology sponsor transitioned from physical TMFs to a fully validated electronic system. Physical records were scanned into PDF/A format and stored on an Annex 11 compliant platform. The move reduced retrieval time from 3 days to under 30 minutes. During a joint inspection by EMA and TGA, inspectors praised the traceability and completeness of the eArchive.

Best Practices for Archiving Decision-Making

1. Assess trial size, scope, and site capabilities
2. Evaluate regional regulatory retention periods
3. Develop SOPs for both physical and electronic storage
4. Implement a hybrid model when appropriate
5. Train all relevant staff in archiving compliance

Conclusion: Choose Wisely, Document Thoroughly

Archiving physical vs electronic clinical records is not just a format choice—it’s a compliance decision that affects trial credibility, regulatory success, and inspection readiness. A strong strategy considers regulatory expectations, data volume, budget, and access needs. Whether paper, electronic, or hybrid, all records must be preserved securely and accessibly for the entire retention period mandated by each jurisdiction.

Make archiving a pillar of your trial’s success—because long after a trial ends, the documents must still speak for the science.

Further Reading

• Pharma regulatory requirements
• Stability testing protocols

Archiving Physical vs Electronic Clinical Records: GCP-Compliant Strategies

Archiving clinical records is an essential step in the lifecycle of a clinical trial, ensuring long-term preservation, traceability, and compliance with global Good Clinical Practice (GCP) guidelines. As technology evolves, sponsors face the choice between maintaining physical paper archives or adopting electronic solutions. Understanding the differences, benefits, limitations, and compliance considerations of each approach is vital for informed decision-making. This article compares physical and electronic clinical record archiving under GCP regulations, providing actionable guidance for pharma professionals and clinical trial stakeholders.

Whether you’re managing an eTMF, traditional paper files, or a hybrid model, having a compliant and secure archiving process supports audit readiness and regulatory transparency.

What Are Clinical Records?

Clinical records include any document, form, image, or dataset used to support the conduct, reporting, and verification of a clinical trial. These may encompass:

• Informed Consent Forms (ICFs)
• Case Report Forms (CRFs)
• Investigator Brochures and Protocols
• Source data and lab reports
• Trial Master File (TMF) documentation
• Audit trails and metadata from Electronic Data Capture (EDC) systems

GCP Requirements for Archiving Clinical Records

According to EMA and USFDA guidelines, all essential trial documents must be archived to demonstrate compliance with GCP. The ICH E6(R2) specifies:

• Retention for at least 2 years after the last marketing approval or longer based on regional regulations
• Secure and controlled access
• Readability, retrievability, and audit readiness
• Documented SOPs for archiving procedures

Retention periods vary across regions. For instance, EU law mandates a 25-year minimum retention period for the TMF under EU Regulation 536/2014.

Physical Archiving: Traditional but Reliable

Pros of Physical Archiving:

• Familiar format for regulatory inspectors
• Minimal technological dependency
• Suitable for small-scale or site-based trials

Cons of Physical Archiving:

• High storage space and facility costs
• Risk of physical deterioration (fire, humidity, pests)
• Limited retrievability and searchability
• Transport and access delays for audits

Physical archives must be maintained under GMP documentation standards with environmental controls and access logs.

Electronic Archiving: Efficient and Scalable

Pros of Electronic Archiving:

• Easy access and fast retrieval
• Audit trail and metadata preservation
• Space and cost savings
• Integration with EDC, CTMS, and eTMF systems

Cons of Electronic Archiving:

• Requires validation under 21 CFR Part 11 and EU Annex 11
• Vulnerable to cybersecurity risks if not encrypted
• File format obsolescence risk (non-PDF/A, legacy formats)

To comply with GCP, electronic archives must undergo full computer system validation (CSV) and demonstrate controlled access, integrity, and backup.

Hybrid Model: Best of Both Worlds

Many organizations adopt a hybrid archiving approach:

• Store critical ICFs and CRFs in physical form at site or sponsor level
• Maintain TMF and audit logs in electronic form (eTMF)
• Digitize paper documents for redundancy

This approach supports flexibility, inspector expectations, and disaster recovery preparedness.

Steps for GCP-Compliant Archiving Strategy

1. Define Archiving Policy and SOP

• Identify what documents are archived physically vs electronically
• Set region-specific retention periods
• Specify roles (Archivist, QA, IT, Sponsor)
• Include security, retrieval, and audit procedures

Use reference SOPs from pharma SOP templates to structure internal policies.

2. Implement Secure Storage Systems

• Use access-controlled offsite storage for paper files
• Use encrypted, validated cloud platforms for digital archives
• Maintain backup, disaster recovery, and access logs

3. Ensure Retrieval and Audit Readiness

• Maintain searchable document inventories
• Implement eTMF dashboards with audit logs
• Demonstrate document integrity on retrieval

Timely data access helps meet stability studies correlation and regulatory inquiry timelines.

Case Study: Transitioning to eArchive in a Global Trial

A multinational CRO transitioned from physical to electronic TMF during a Phase III diabetes trial. They validated a Part 11 compliant eArchive, digitized legacy documents, and trained QA staff. Regulatory inspections by Health Canada and EMA showed improved document traceability, reduced query response time, and zero findings related to archiving practices.

Best Practices for Long-Term Archiving

• Use PDF/A and XML formats for future-proof readability
• Maintain parallel logs for both physical and digital archives
• Conduct annual archive audits
• Include archiving strategy in trial planning documents
• Assign clear accountability to sponsors and CROs

Conclusion: Choose the Right Archiving Strategy

Both physical and electronic archiving approaches have their merits and limitations. While physical archives offer a familiar structure, electronic records provide scalability and access efficiency. The right choice depends on trial size, region, technology infrastructure, and budget. Above all, sponsors must ensure that their archiving practices are GCP-compliant, audit-ready, and documented in robust SOPs.

Whether you go physical, electronic, or hybrid, ensure your archiving system supports the long-term integrity and accessibility of your clinical trial data.

Further Reading:

• Drug regulatory compliance
• Real-time stability studies